New Mexico Educational Retirement Board purchased a new stake in Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 14,600 shares of the medical research company’s stock, valued at approximately $1,429,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in IQV. Winslow Evans & Crocker Inc. purchased a new position in Iqvia in the 4th quarter valued at about $123,000. IFP Advisors Inc purchased a new position in Iqvia in the 4th quarter valued at about $200,000. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in Iqvia in the 4th quarter valued at about $209,000. Atria Investments LLC purchased a new position in Iqvia in the 4th quarter valued at about $218,000. Finally, First Quadrant L P CA purchased a new position in Iqvia in the 4th quarter valued at about $221,000. Hedge funds and other institutional investors own 96.09% of the company’s stock.
Iqvia Holdings Inc (NYSE:IQV) opened at $100.26 on Wednesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 1.22 and a current ratio of 1.19. Iqvia Holdings Inc has a 12-month low of $75.94 and a 12-month high of $110.67. The company has a market cap of $21,183.34, a PE ratio of 22.07, a PEG ratio of 1.81 and a beta of 0.61.
Iqvia (NYSE:IQV) last issued its earnings results on Wednesday, February 14th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.34 by ($0.02). Iqvia had a return on equity of 13.03% and a net margin of 13.44%. The business had revenue of $2.16 billion during the quarter, compared to the consensus estimate of $2.14 billion. During the same period in the prior year, the business earned $1.09 EPS. The business’s revenue was up 10.7% on a year-over-year basis. research analysts forecast that Iqvia Holdings Inc will post 4.1 EPS for the current fiscal year.
In other Iqvia news, insider Ari Bousbib sold 46,080 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $101.79, for a total value of $4,690,483.20. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider James H. Erlinger III sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, January 17th. The stock was sold at an average price of $99.97, for a total transaction of $999,700.00. The disclosure for this sale can be found here. Insiders sold 8,727,078 shares of company stock worth $890,124,079 in the last three months. 6.40% of the stock is currently owned by corporate insiders.
A number of research firms have weighed in on IQV. ValuEngine raised shares of Iqvia from a “hold” rating to a “buy” rating in a research report on Tuesday. Zacks Investment Research cut shares of Iqvia from a “hold” rating to a “sell” rating in a research report on Tuesday. Royal Bank of Canada set a $118.00 price objective on shares of Iqvia and gave the company a “buy” rating in a research report on Thursday, February 15th. Piper Jaffray Companies reissued a “hold” rating and issued a $103.00 price objective on shares of Iqvia in a research report on Thursday, February 15th. Finally, JPMorgan Chase & Co. increased their price target on shares of Iqvia from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $110.02.
ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/21/new-mexico-educational-retirement-board-purchases-new-holdings-in-iqvia-holdings-inc-iqv.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.